Understanding The Differences & Similarities of Mounjaro and Wegovy: Are They The Same?

Everything You Need To Know About Mounjaro & Wegovy

What is Mounjaro?

Mounjaro is actually the brand name for the medication that is manufactured by Eli Lilly. It represents the latest generation of metabolic treatments which offers a multi-hormonal approach to health.
While it is specifically developed and licensed in treating Type 2 Diabetes (T2DM), the significant impact of Mounjaro on weight has significantly led to its wider reach adoption for treating chronic weight management and obesity.
According to the NICE guidance, Mounjaro is specifically approved for use within the NHS for patients dealing Type 2 Diabetes and who actually meet the specific criteria. For weight loss, while it has already received the MHRA regulatory approval, its availability on the NHS for obesity is still managed by following a specialist weight management service instead of a general practice.

What is Wegovy?

It is specifically the weight-loss- brand of semaglutide which is manufactured by Novo Nordisk.
Unlike its sister brand named Ozempic which is specifically licensed for diabetes, Wegovy is specifically licensed in the UK in treating chronic weight management in adults with a BMI of 30 or greater or 27 with at least presenting any one weight-related comorbidity.
The NHS England has also approved Wegovy for use specifically within controlled and by following specialist weight management settings. It is typically prescribed together with a reduced-calorie diet and patients are also advised to increase their physical activity in order to maximize its long-term results.

What Are Their Key Ingredients and Active Compounds

Mounjaro

It consists of an active ingredient called tirzepatide. This is a first-in-class twincretin. It is also a dual GIP and GLP-1 receptor agonist. This works by mimicking two separate hormones, which directly affects your hunger and glucose levels through multiple biological pathways simultaneously.

Wegovy

It consists of an active ingredient called semaglutide. This is a selective GLP-1 receptor agonist. It works by mimicking the natural GLP-1 hormone which targets the areas of your brain that are responsible for regulating your appetite and food intake. While it only targets one receptor, its potency in suppressing hunger or any food noise has made it the core of modern weight-loss medicine.

Structural & Molecular Note

The primary difference between Mounjaro and Wegogy is their receptor synergy. Semaglutide is a specifically a modified version of a single natural hormone while tirzepatide is a single molecule engineered specifically designed to not only help with blood sugar but also to potentially enhance the body’s ability in breaking down fat and improving the body’s energy expenditure.

Mounjaro and Wegovy treatment

Effective & professional doctor-led Mounjaro and Wegovy at our central London clinic

Get Started Request a Call

The Difference Between Tirzepatide & Semaglutide

While they are both administered through a weekly injection and they both belong to the same family of incretin mimetics, they significantly have differences such as the following:

How It Works: The primary difference of the two is that, the semaglutide (Wegovy) is a single-hormone agonist which targets only the GLP-1 receptor while the tirzepatide (Mounjaro) works as a dual-hormone agonist which activates both GLP-1 and GIP receptors. This may provide a more comprehensive metabolic response.
Manufacturer and Brand: The semaglutide is specifically produced by Novo Nordisk while the tirzepatide was developed by Eli Lilly.
Dose and Potent: Because both consist of different molecules, their dosages are not interchangeable. Semaglutide can reach a maximum maintenance dose of 2.4 mg, while tirzepatide can involve a much broader titration range that can be up to a maximum of 15 mg.
Half-Life and Frequency: Both Mounjaro and Wegovy have been designed for long-term stability in the bloodstream. Semaglutide has a half-life which is approximately seven days while tirzepatide is roughly five days. Both medications are specifically designed for a once a week administration.
Clinical Outcomes: According to the Large-scale clinical trials, it suggests that while both medications are highly effective, they found out that the dual-action nature of tirzepatide is generally leading into a higher average percentage of total body weight loss rather than the single-action semaglutide.

How They Work

The Role of GLP-1

Both Mounjaro & Wegovy are utilizing the power of GLP-1 receptor agonists. These means that they work by mimicking a hormone which is naturally produced in your gut after you eat. They work through three primary mechanisms. Here are those:

Slowing Down Gastric Emptying: They work by slowing down the speed at which food actually leaves your stomach. This leads you to feeling full for a longer period of time.
Sending Signals To The Brain: They work best in targeting the area where it is responsible for food noise. Once it’s targeted, it reduces the amount of cravings that you would always experience before taking the medication.
Regulates Insulin Level: They work by prompting the pancreas in releasing insulin as a response to the rising blood sugar while inhibiting glucagon. This actually helps in stabilizing your glucose levels.

Why You Need to Increase Your Wegovy Dose & How It Works

How Long Does Mounjaro Take to Work? A Comprehensive Guide to Expectations

The Tirzepatide Advantage

While Mounjaro has a GLP-1 is the heavy lifter in suppressing appetite, GIP is actually a metabolic enhancer.

Enhancing Metabolic System: GIP specifically works by improving how your body metabolizes fats and sugars. This also potentially protects your body against any side effects like nausea which is typically associated with GLP-1 while it also boosts your insulin secretion.
Synergy: Through hitting two receptors instead of one, tirzepatide is theoretically providing a more potent signal and it is more aggressive towards metabolic dysfunction. This often translates into a higher weight loss percentage according to clinical data.

All About Their Dosage & Administration

Dosing Schedules & Titration

To ensure that your body is adapting to these potent hormones, both Mounjaro and Wegovy require a gradual titration process. This is essential in order to minimize any gastrointestinal issues that you might experience.

Wegovy: This typically follows a 5-step escalation which starts at 0.25 mg then further leads to 0.5 mg, 1.0 mg, 1.7 mg, and reaches a maximum maintenance dose of 2.4 mg.
Mounjaro: This typically follows a more granular schedule. You would typically start at 2.5 mg then gradually increase by 2.5 mg increments every after four weeks, then reach a maximum dose of up to 15 mg.
Efficacy Targets: According to the Clinical trials for obesity, it consistently shows that by reaching the maximum tolerated dose for both medications, it would actually provide the most significant long-term results.

Administration Techniques

Both Mounjaro and Wegovy are typically delivered through subcutaneous injections. This means that they are injected into the fatty tissue just under the skin instead of injecting it on the vein or muscle.

Injection Sites: The most common body area to inject the medication is at the abdomen which needs to be at least two inches from the belly button, the front of your thigh, and/or at the outer back of your upper arm.
Storage and Handling: In the UK, these medication pens should strictly be stored in the refrigerator which has 2°C to 8°C until they are first used. Once it is already in use, you can typically store it at room temperature with a limited period of time. This is usually up to 21–30 days but sometimes it will still depend on the specific brand.
The Click System of Both Medication: Both the manufacturers are using a pre-filled, multi-dose or single-dose pens which is specifically designed in providing an easy to use at home. This has very fine needles which the majority of the patients find actually painless.

The Side Effects & Their Safety

Common Side Effects

The most frequent side effects that are present for both Mounjaro and Wegovy are gastrointestinal (GI) in nature. This affects more than 1 in 10 patients. This usually happens because of how the drugs are slowing down the digestive system in inducing fullness.

Common Side Effects: You might experience side effects like nausea, vomiting, diarrhea, and constipation. These are commonly reported by patients who have experienced it. According to some as well, people who are taking the medication might also experience some abdominal discomfort, indigestion, and an increased burping or gas.
Patterns To Monitor: These symptoms are mostly acute during the titration phase. Once you’ve already reached your steady maintenance dose, your body will typically habituate and the side effects will begin to slowly fade over time.

Conclusion

In summary, while both Mounjaro and Wegovy actually share the primary goal of sustainable weight management, they significantly achieve this in different biological pathways. Mounjaro works as a dual agonist while Wegovy works only on the GLP-1 receptor. In choosing which medication you should take, you should keep in mind which medication actually aligns with your clinical profile. It is why having a thorough consultation with an experienced clinic and team is very essential before taking any medication between Mounjaro and Wegovy. It’s not only about the pricing and their benefits, but also making sure that it will actually help you in achieving your desired weight goals.

Reserve a mounjaro appointment

One of our experts will be more than happy to answer any questions you have.

02074364441

Book Appointment

or Request a Callback
or Chat via Whatsapp Whatsapp logo